Fogorvosi szemle, 2007 (100. évfolyam, 1-6. szám)

2007-10-01 / 5. szám

FOGORVOSI SZEMLE

100. évf. 5. sz. 2007.

229

human periodontal fibroblasts: proliferation, morphology and root surface colonization. An in vitro study. J Periodont Res 2003; 38: 568-574.

23. Davenport DR, Mailhot JM, Wataha JC, Billman MA, Sharawy MM, Shrout MK: Effects of enamel matrix protein application on the viability, proliferation, and attachment of human periodontal ligament fibroblasts to diseased root surfaces in vitro. J Clin Periodontol 2003; 30: 125-131.

24. Van der Pauw MT, Everts V, Beertsen W: Expression of integrins by human periodontal ligament and gingival fibroblasts and their involvement in fibroblast adhesion to enamel matrix-derived proteins. J Periodont Res 2002; 37: 317-323.

25. Tokiyasu Y, Takata T, Saygin E, Somerman MJ: Enamel factors regulate expression of genes associated with cementoblats. J Periodontol 2000; 71: 1829-1839.

26. Inoue M, LeGeros RZ, Hoffman C, Diamond K, Rosenberg PA, Craig RG: Effect of enamel matrix proteins on the phenotype expression of periodontal ligament cells cultured on dental materials. J Biomed Mater Res A 2004; 69: 172-179.

27. Gurpinar A, Onur MA, Cehreli ZC, Tasman F: Effect of enamel matrix derivative on mouse fibroblasts and marrow stromal osteoblasts. J Biomater Appl 2003; 18: 25-33.

28. Koike Y, MurakamiS, MatsuzakaK, Inoue T: The effect of Emdogain on ectopic bone formation in tubes of rat demineralized dentin matrix. J Periodont Res 2005; 40: 385-394.

29. Baker DL, Stanley Pavlow SA, Wikesjö UM: Fibrin clot adhesion to dentin conditioned with protein constructs: an in vitro proof-of-principle study. J Clin Periodontol 2005; 32: 561-566.

30. Kawase T, Okuda K, Yoshie H, Burns DM: Cytostatic action of enamel matrix derivative (EMDOGAIN®) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodont Res 2000; 35: 291-300.

31. Boyan BD, Weesner TC, Lohmann CH, Andreacchio D, Carnes DL, Dean DD, Cochran DL, Schwarz Z: Porcine fetal enamel matrix derivative enhances bone formation induced by demineralized freeze dried bone allograft in vivo. J Periodontol 2000; 71: 1278- 1286.

32. Schwartz Z, Carnes DL Jr, Pulliam R, LohmannCH, Sylvia VL, Liu Y, Dean DD, Cochran DL, Boyan BD: Porcine fetal enamel matrix derivative stimulates proliferation but not differentiation of pre-osteoblastic 2T9 cells, inhibits proliferation and stimulates differentiation of osteoblast-like MG63 cells, and increases proliferation and differentiation of normal human osteoblast NHOst cells. J Periodontol 2000; 71: 1287-1296.

33. TAKAYANAGI K, OsawaG, Nakaya H, Cochran DL, Kamoi K, OatesTW: Effects of enamel matrix derivative on bone-related mRNA expression in human periodontal ligament cells in vitro. J Periodontol 2006; 77: 891-898.

34. Schwarz F, Rothamel D, Herten M, Sculean A, Scherbaum W, Becker J: Effect of enamel matrix protein derivative on the attachment, proliferation, and viability of human SaOs(2) osteoblasts on titanium implants. Clin Oral Investig 2004; 8: 165-171.

35. Mizutani S, Tsuboi T, Tazoe M, Koshihara Y, Goto S, Togari A: Involvement of FGF-2 in the action of Emdogain on normal human osteoblastic activity. Oral Dis 2003; 9: 210-217.

36. MatsudaN, HorikawaM, WatanabeM, KitagawaS, Kudo Y, Takata T: Possible involvement of extracellular signal-ragulated kinases 1/2 in mitogenic response of periodontal ligament cells to enamel matrix derivative. EurJ Oral Sei 2002; 110: 439-444.

37. Hägewald S, Pischon N, Jawor P, Bernimoulin JP, Zimmermann B: Effects of enamel matrix derivative on proliferation and differentiation of primary osteoblasts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 243-249.

38. He J, Jiang J, Safavi KE, Spangberg LS, Zhu Q: Direct contact between enamel matrix derivative (EMD) and osteoblasts is not required for EMD-induced cell proliferation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98: 370-370.

39. Shimizu E, Nakajima Y, Kato N, Nakayama Y, Saito R, Samoto H, Ogata Y: Regulation of rat bone sialoprotein gene transcription by enamel matrix derivative. J Periodontol 2004; 75: 260-267.

40. Hattar S, Asselin A, Greenspan D, OboeufM, BerdalA, Sautier JM: Potential of biomimetic surfaces to promote in vitro osteoblast-like cell differentiation. Biomaterials 2005; 26: 839-848.

41. Parkar MH, Tonetti M: Gene expression profiles of periodontal ligament cells treated with enamel matrix proteins in vitro: analysis using cDNA arrays. J Periodontol 2004; 75: 1539-1546.

42. Sculean A, Auschill TM, Donos N, Brecx M, Arweiler N: Effect of an enamel matrix derivative (Emdogain®) on ex vivo dental plaque vitality. J Clin Periodontol 2001; 28: 1074-1078.

43. Arweiler NB, Auschill TM, Donos N, Sculean A: Antibacterial effect of an enamel matrix protein derivative on in vivo dental biofilm vitality. Clin Oral Invest 2002; 6: 205-209.

44. Spahr A, Lyngstadaas SP, Boeckh C, Andersson C, Podbielski A, Haller B: Effect of the enamel matrix derivative Emdogain® on the growth of periodontal pathogens in vitro. J Clin Periodontol 2001; 29: 62-72.

45. Newman SE, CosciaSA, Jotwani R, IaconoVJ, Cutler CW: Effects of enamel matrix derivative on Porphyromonas gingivalis. J Periodontol 2003; 74: 1191-1195.

46. Walter C, Jawor P, Bernimoulin JP, Hagewald S: Moderate effect of enamel matrix derivative (Emdogain®) on Porphyromonas gingivalis growth in vitro. Arch Oral Biol 2005.

47. Inaba H, Kawai S, Nakayama K, Okahashi N, Amano A: Effect of enamel matrix derivative on periodontal ligament cells in vitro is diminished by Porphyromonas gingivalis. J Periodontol 2004; 75: 858- 865.

48. Rincon JC, Haase HR, Bartold PM: Effect of Emdogain on human periodontal fibroblasts in an in vitro wound healing model. J Periodont Res 2003; 38: 290-295.

49. Mirastschijski U, Konrad D, Lundberg E, Lyngstadaas SP, Jorgensen LN, Agren MS: Effects of a topical enamel matrix derivative on skin wound healing. Wound Repair Regen 2004; 12: 100-108.

50. Yuan K, Chen CL, Lin MT: Enamel matrix derivative exhibits angiogeniceff ectin vitro andinamurine model. JCIinPeriodontol2003',30: 732-738.

51. Myhre AE, Lyngstaadas SP, Dahle MK, Stuestol JF, Foster SJ, Thiemermann C, Lilleaasen P, Wang JE, Aasen AO: Anti-inflammatory properties of enamel matrix derivative in human blood. J Periodont Res 2006; 41: 208-213.

52. TakayamaT, Suzuki N, Narukawa M, Goldberg HA, Otsuka K, Ito K: Enamel matrix derivative is a potent inhibitor of breast cancer cell attachment to bone. Life Sei2005; 76: 1211-1221.

53. Hamamoto Y, Kawasaki N, Jarnbring F, Hammarström L: Effects and distribution of the enamel matrix derivative Emdogain in the periodontal tissues of rat molars transplanted to the abdominal wall. Dent Traumatol 2002; 18: 12-33.

54. Ónodéra H, Shibukawa Y, Sugito H, Ota M, Yamada S: Periodontal regeneration in intrabony defects after application of enamel matrix proteins with guided tissue regeneration: an experimental study in dogs. Biomed Res 2005; 26: 69-77.

55. Chano L, Tenenbaum HC, Lekic PC, Sodek J, McCulloch CA: Emdogain regulation of cellular differentiation in wounded rat periodontium. J Periodont Res 2003; 38: 164-174.

56. Hammaström L, Heul L, Gestrelius S: Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Periodontol 1997; 24: 669-677.

57. Sculean A, Donos N, Brecx M, Karring T, Reich E: Healing of fenestration-type defects following treatment with guided tissue regeneration or enamel matrix proteins. An experimental study in monkeys. Clin Oral Invest 2000; 4: 50-56.

58. Sculean A, Donos N, Reich E, Brecx M, Karring T: Healing of recession-type defects following treatment with enamel matrix proteins or guided tissue regeneration. A pilot study in monkeys. J Parodontol Implant Orale 2000; 19: 19-31.

59. Sculean A, Donos N, Brecx M, Reich E, Karring T: Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. An experimental study in monkeys. J Clin Periodontol 2000; 27: 466-472.

60. Sakallioglu U, Acikgoz G, Ayas B, Kirtiloglu T, Sakallioglu E: Healing of periodontal defects treated with enamel matrix proteins